Metabolon Continues Expanding Service Line, Adds mVivo™ As Its Third Packaged Solution

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery, today announced the launch of mVivo™, a service that allows researchers to gain a deeper understanding of the effects of investigational drugs during animal testing. With the introduction of mVivo, Metabolon completes their three product series of metabolomic drug safety and efficacy testing solutions, spanning the entire drug discovery and development workflow.